An estimated 170 million people worldwide carry the hepatitis C virus (HCV), and in more developed countries the prevalence and incidence of HCV is particularly high among injecting drug users (IDUs). Spontaneous clearance of HCV infection and reinfection is well recognized but the level of protecti
Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users
β Scribed by S. Bowden; R. McCaw; P. A. White; N. Crofts; C. K. Aitken
- Book ID
- 108885758
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 40 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Six major genotypes of the hepatitis C virus (HCV) have been described; it is assumed to be uncommon for genotypes to change in chronically infected individuals. Venous blood samples obtained from VietnameseβAustralian injecting drug users who participated in successive studies conducte
## Abstract Hepatitis C virus subtype 3a (HCVβ3a) originates from Asia and has spread widely among injecting drug users as well as other patient groups in industrialized countries. HCV subtype 3a infection remains highly prevalent and frequently transmitted in the population of intravenous drug use
## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user
## Abstract While much is known about hepatitis C virus (HCV) among injecting drug users (IDUs), there is scant information about the risk of HCV infection to nonβinjecting sexual partners of injecting drug users; it is possible that such individuals may have a greater risk of acquiring HCV than an